|
Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis |
Maryland* |
Completed |
Multiple Sclerosis |
|
Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis |
Maryland* |
Completed |
Multiple Sclerosis |
|
Relating Genetic and Environmental Risk Scores to Multiple Sclerosis Susceptibility |
Canada |
Completed |
Multiple Sclerosis |
|
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance Myography |
Massachusetts |
Completed |
Amyotrophic Lateral Sclerosis (ALS) |
|
Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS) |
Michigan |
Completed |
ALS, Amyotrophic Lateral Sclerosis |
|
Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis |
Maryland* |
Completed |
Multiple Sclerosis |
|
Rolipram to Treat Multiple Sclerosis |
Maryland |
Completed |
Multiple Sclerosis |
|
Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis |
Multiple U.S. Locations |
Completed |
Multiple Sclerosis |
|
Minocycline to Treat Amyotrophic Lateral Sclerosis |
International Locations |
Completed |
Amyotrophic Lateral Sclerosis |
|
A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients |
Maryland |
Completed |
Multiple Sclerosis |
